GYRE THERAPEUTICS INC (GYRE) Institutional Shareholders

GYRE THERAPEUTICS INC (GYRE) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $57.11M in GYRE holdings during the latest filing period.

Hsg Holding Ltd is currently the largest disclosed institutional shareholder of GYRE tracked by InsiderSet, reporting ownership valued at approximately $24.71M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $26.93M, representing an estimated gain of +8.95% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 93% of the total disclosed GYRE value among the investors covered in this analysis. Major shareholders include Hsg Holding Ltd, Blackrock, Inc., Octagon Capital Advisors Lp, and several other long-term asset managers with concentrated positions in GYRE THERAPEUTICS INC (GYRE).

This page ranks the largest institutional GYRE shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

57

Total Reported Value

$57.11M

Largest Holder

Hsg Holding Ltd

Largest Position

$24.71M

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

70

Funds Exiting Positions

1

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Hsg Holding Ltd2.06%3,750,299$24,714,470$26,927,147+$2,212,677+8.95%
Blackrock, Inc.0.00%993,943$6,550,085$7,136,511+$586,426+8.95%
Octagon Capital Advisors Lp0.58%954,416$6,289,601$6,852,707+$563,106+8.95%
Vanguard Capital Management Llc0.00%876,927$5,778,949$6,296,336+$517,387+8.95%
Geode Capital Management, Llc0.00%532,950$3,513,176$3,826,581+$313,405+8.92%
State Street Corp0.00%245,402$1,617,199$1,761,986+$144,787+8.95%
Charles Schwab Investment Management Inc0.00%184,286$1,214,445$1,323,173+$108,728+8.95%
Northern Trust Corp0.00%169,537$1,117,249$1,217,276+$100,027+8.95%
Sbi Securities Co., Ltd.0.02%166,750$1,098,883$1,197,265+$98,382+8.95%
Vanguard Fiduciary Trust Co0.00%151,073$995,571$1,084,704+$89,133+8.95%
Vanguard Portfolio Management Llc0.00%123,953$816,850$889,983+$73,133+8.95%
Goldman Sachs Group Inc0.00%86,235$568,289$619,167+$50,878+8.95%
Bank Of New York Mellon Corp0.00%62,750$413,523$450,545+$37,022+8.95%
Morgan Stanley0.00%41,691$274,743$299,341+$24,598+8.95%
Alliancebernstein L.P.0.00%24,590$171,392$176,556+$5,164+3.01%
Strs Ohio0.00%25,800$170,022$185,244+$15,222+8.95%
Dimensional Fund Advisors Lp0.00%25,268$166,516$181,424+$14,908+8.95%
Nuveen, Llc0.00%24,505$161,488$175,946+$14,458+8.95%
Ubs Group Ag0.00%18,763$123,649$134,718+$11,069+8.95%
Millennium Management Llc0.00%18,488$121,836$132,744+$10,908+8.95%
Deutsche Bank Ag\0.00%17,939$118,218$128,802+$10,584+8.95%
Rhumbline Advisers0.00%16,865$111,131$121,091+$9,960+8.96%
Wells Fargo & Company/Mn0.00%16,297$107,397$117,012+$9,615+8.95%
Price T Rowe Associates Inc0.00%15,031$100,000$107,923+$7,923+7.92%
Fmr Llc0.00%14,974$98,679$107,513+$8,834+8.95%
Royal Bank Of Canada0.00%13,195$87,000$94,740+$7,740+8.90%
Bank Of America Corp0.00%12,525$82,539$89,930+$7,391+8.95%
Polymer Capital Management (Us) Llc0.01%11,780$77,630$84,580+$6,950+8.95%
Vanguard Global Advisers, Llc0.00%9,983$65,788$71,678+$5,890+8.95%
Police & Firemen'S Retirement System Of New Jersey0.00%9,011$59,382$64,699+$5,317+8.95%
Citigroup Inc0.00%8,586$56,582$61,647+$5,065+8.95%
Mirae Asset Global Etfs Holdings Ltd.0.00%8,446$55,659$60,642+$4,983+8.95%
Jpmorgan Chase & Co0.00%7,831$50,510$56,227+$5,717+11.32%
State Of Alaska, Department Of Revenue0.00%5,219$34,000$37,472+$3,472+10.21%
Russell Investments Group, Ltd.0.00%3,783$24,930$27,162+$2,232+8.95%
Bnp Paribas Financial Markets0.00%3,486$22,973$25,029+$2,056+8.95%
Barclays Plc0.00%3,228$21,273$23,177+$1,904+8.95%
New York State Common Retirement Fund0.00%2,700$17,793$19,386+$1,593+8.95%
Tower Research Capital Llc (Trc)0.00%2,469$16,271$17,727+$1,456+8.95%
Legal & General Group Plc0.00%2,054$13,536$14,748+$1,212+8.95%
Ameritas Investment Partners, Inc.0.00%683$4,501$4,904+$403+8.95%
Activest Wealth Management0.00%533$3,512$3,827+$315+8.97%
Arax Advisory Partners0.00%246$1,621$1,766+$145+8.96%
California State Teachers Retirement System0.00%166$1,094$1,192+$98+8.95%
Sterling Capital Management Llc0.00%161$1,061$1,156+$95+8.95%
Gamma Investing Llc0.00%146$962$1,048+$86+8.97%
Cwm, Llc0.00%104$725$747+$22+3.00%
Physician Wealth Advisors, Inc.0.00%82$541$589+$48+8.83%
Goalvest Advisory Llc0.00%50$330$359+$29+8.79%
Osaic Holdings, Inc.0.00%44$288$316+$28+9.69%
Showing 50 of 57

Frequently asked questions about GYRE

  • Who owns the most GYRE stock?

    The largest holders of GYRE are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for GYRE THERAPEUTICS INC (GYRE).

  • Is GYRE widely held by superinvestors?

    Many widely followed stocks like GYRE appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly GYRE is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.